A novel STAT3 mutation in a patient with hyper-immunoglobulin E syndrome.

Adi Ovadia(Tel Aviv University), Ilan Dalal(Tel Aviv University), Aharon Kessel(Technion – Israel Institute of Technology), Esther Leshinsky‐Silver(Tel Aviv University)

PubMed

January 1, 2015

Cited by 1

Related Papers

The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria

|Allergy|2021|1.2k

Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients

|Allergy|2004|301

Human CD19+CD25high B regulatory cells suppress proliferation of CD4+ T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells

|Autoimmunity Reviews|2011|293

Intravenous Immunoglobulin Therapy Affects T Regulatory Cells by Increasing Their Suppressive Function

|The Journal of Immunology|2007|229

Age-related autoimmunity

|BMC Medicine|2013|196